JoshuaMichaelBaumlMD

PubMed

• 2 citations
  A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
  Charu Aggarwal, Alisha P Maity, Joshua M Bauml, Qi Long, Tomas Aleman, Christine Ciunci, Christopher D'Avella, Melissa Volpe, Evan Anderson, Lisa McCormick Jones, Lova...> ;The Oncologist. 2023 Jul 5
• 8 citations
  Biomarkers predictive of response to pembrolizumab in head and neck cancer.
  David G Pfister, Robert I Haddad, Francis P Worden, Jared Weiss, Ranee Mehra, Laura Q M Chow, Stephen V Liu, Hyunseok Kang, Nabil F Saba, Lori J Wirth, Ammar Sukari, E...> ;Cancer Medicine. 2023 Mar 1
• Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck.
  Derek D Kao, Rocco M Ferrandino, Joshua M Bauml, Deborah C Marshall, Richard Bakst, Scott Roof, Yeun-Hee A Park, Keith M Sigel> ;Oral Oncology. 2022 Dec 1
• 8 citations
  Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors.
  Nicolas Girard, Anna Minchom, Sai-Hong Ignatius Ou, Shirish M Gadgeel, José Trigo, Santiago Viteri, Joshua M Bauml, Anil Londhe, Parthiv Mahadevia, Lyudmila Bazhenova> ;Clinical Lung Cancer. 2022 Nov 1
• 5 citations
  Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy.
  Apurva Singh, Hannah Horng, Leonid Roshkovan, Joanna K Weeks, Michelle Hershman, Peter Noël, José Marcio Luna, Eric A Cohen, Lauren Pantalone, Russell T Shinohara, Jos...> ;Scientific Reports. 2022 Jun 15
• 13 citations
  High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.
  A J Piper-Vallillo, Julia K Rotow, Jacqueline V Aredo, Khvaramze Shaverdashvili, Jia Luo, Jennifer W Carlisle, Hatim Husain, Alona Muzikansky, Rebecca S Heist, Deepa R...> ;JTO Clinical and Research Reports. 2022 Jun 1
• 1 citations
  Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
  Christine A Ciunci, Jacob B Reibel, Tracey L Evans, Rosemarie Mick, Joshua M Bauml, Charu Aggarwal, Melina E Marmarelis, Aditi P Singh, Christopher D'Avella, Roger B C...> ;Clinical Lung Cancer. 2022 Jun 1
• 13 citations
  Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after pla...
  Anna Minchom, Santiago Viteri, Lyudmila Bazhenova, Shirish M Gadgeel, Sai-Hong Ignatius Ou, José Trigo, Joshua M Bauml, Daniel Backenroth, Archan Bhattacharya, Tracy L...> ;Lung Cancer. 2022 Jun 1
• 9 citations
  Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study.
  Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei-Ting Hwang, Michelle Andronov, David M Dibardino, Christoph T Hutchinson, Kevin C Ma, Anthony ...> ;JTO Clinical and Research Reports. 2022 Apr 1
• 2 citations
  Sex-Related Differences in Outcomes for Oropharyngeal Squamous Cell Carcinoma by HPV Status.
  Derek D Kao, Rocco M Ferrandino, Deborah C Marshall, Tinaye Mutetwa, Brett Miles, Joshua M Bauml, Keith M Sigel> ;International Journal of Otolaryngology. 2022 Jan 1
• 3 citations
  Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinoma.
  Justin R. Shinn, Ryan M. Carey, Leila J. Mady, David Shimunov, Harman S. Parhar, Steven B. Cannady, Karthik Rajasekaran, John N. Lukens, Alexander Lin, Samuel Swisher-...> ;Oral Oncology. 2021 Oct 29
• 21 citations
  Comparative Clinical Outcomes for Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations
  Lyudmila Bazhenova, Anna Minchom, Santiago Viteri, Joshua Bauml, Sai-Hong Ignatius Ou, Shirish M. Gadgeel, Jose Manuel Trigo, Daniel Backenroth, Tracy Li, Anil Londhe,...> ;Lung Cancer. 2021 Nov 6
• 17 citations
  Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
  Joshua Bauml, Bob T. Li, Vamsidhar Velcheti, Ramaswamy Govindan, Alessandra Curioni-Fontecedro, Christophe Dooms, Toshiaki Takahashi, Andrew W. Duda, Justin I. Odegaar...> ;Lung Cancer. 2021 Oct 19
• 5 citations
  Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
  Vivek Nimgaonkar, Charu Aggarwal, Abigail T. Berman, Peter Gabriel, Lawrence N. Shulman, John C. Kucharczuk, Megan Roy, Joshua Bauml, Aditi P. Singh, Roger B. Cohen, C...> ;BMC Cancer. 2021 Oct 11
• 8 citations
  Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
  Christopher M. Wright, Daniel Y. Lee, David Shimunov, Ruben Carmona, Andrew R. Barsky, Lova Sun, Roger B. Cohen, Joshua Bauml, Robert M. Brody, Devraj Basu, Christophe...> ;Oral Oncology. 2021 Oct 1
• 240 citations
  Amivantamab in EGFR exon 20 insertion-mutated non-small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study
  Keunchil Park, Eric B. Haura, Natasha B. Leighl, Paul Mitchell, Catherine A. Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K. ...> ;Journal of Clinical Oncology. 2021 Aug 2
• 5 citations
  Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
  Harman S. Parhar, Gregory S. Weinstein, Bert W. O'Malley, David Shimunov, Christopher H. Rassekh, Ara A. Chalian, Jason G. Newman, Devraj Basu, Steven B. Cannady, Kart...> ;Head & Neck. 2021 Jun 8
• 11 citations
  Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
  Ryan M. Carey, Robert M. Brody, David Shimunov, Justin R. Shinn, Leila J. Mady, Karthik Rajasekaran, Steven B. Cannady, Alexander Lin, John N. Lukens, Joshua Bauml, Ro...> ;The Laryngoscope. 2021 Jun 2
• 20 citations
  Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
  Christina M. Yver, David Shimunov, Gregory S. Weinstein, Karthik Rajasekaran, Steven B. Cannady, John N. Lukens, Alexander Lin, Samuel Swisher-McClure, Roger B. Cohen,...> ;Oral Oncology. 2021 Jul 1
• 37 citations
  Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrol...
  Jeffrey C. Thompson, Erica L. Carpenter, Benjamin A. Silva, Jamie Rosenstein, Austin L. Chien, Katie Quinn, Carin R. Espenschied, Allysia J. Mak, Lesli A. Kiedrowski, ...> ;JCO Precision Oncology. 2021 Mar 19
• 18 citations
  Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
  Lova Sun, Christiana Davis, Wei-Ting Hwang, Seth Jeffries, Lydia Frenzel Sulyok, Melina E. Marmarelis, Aditi P. Singh, Abigail T. Berman, Steven J. Feigenberg, William...> ;Clinical Lung Cancer. 2021 Jan 1
• 17 citations
  Increased rate of recurrence and high rate of salvage in patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma with adverse features trea...
  Ryan M. Carey, David Shimunov, Gregory S. Weinstein, Steven B. Cannady, John N. Lukens, Alexander Lin, Samuel Swisher-McClure, Joshua Bauml, Charu Aggarwal, Roger B. C...> ;Head & Neck. 2021 Apr 1
• 3 citations
  Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older Patients.
  Harman S. Parhar, David Shimunov, Jason G. Newman, Steven B. Cannady, Karthik Rajasekaran, Bert W. O’ Malley, Ara A. Chalian, Christopher H. Rassekh, Roger B. Cohen, A...> ;JAMA Otolaryngology-- Head & Neck Surgery. 2020 Dec 1
• Next-generation Sequencing of Cerebrospinal Fluid: How Can a Liquid be Like a Solid?
  Melina E. Marmarelis, Joshua Bauml> ;Clinical Cancer Research. 2020 Dec 1
• 15 citations
  Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
  Ravi B. Parikh, Kyle W. Robinson, Sumedha Chhatre, Elina Medvedeva, John Cashy, Shika Veera, Joshua Bauml, Tito Fojo, Amol S. Navathe, S. Bruce Malkowicz, Ronac Mamtan...> ;JAMA Network Open. 2020 Sep 1
• Join now to see all

Journal Articles

• Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus–Associated Oropharyngeal Carcinoma in Older Patients  
  Harman S Parhar, Karthik Rajasekaran, Ara A Chalian, Christopher H Rassekh, Roger B Cohen, Joshua Bauml, Gregory S Weinstein, Robert M Brody, JAMA Otolaryngology–Head & Neck Surgery
• Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data  
  Ravi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
• Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer  
  Gregory S Weinstein, Charu Aggarwal, Roger B Cohen, Joshua Bauml, Alexander Lin, Clinical Cancer Research
• Thoracic Imaging of Non-Small Cell Lung Cancer Treated with Anti-Programmed Death Receptor-1 Therapy  
  Sharyn I Katz, Arun C Nachiappan, Joshua Bauml, Stephen Bagley, Charu Aggarwal, Corey Langer, ScienceDirect
• A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiatio...  
  Joshua Bauml, Sharon X Xie, Courtney Penn BA, Krupali Desai, Kimberly W Dong, Deborah Watkins Bruner Neha Vapiwala and Jun James Mao, Journal of Palliative Care and Medicine, 2012
• Join now to see all

Lectures

• Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran's health ... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018